{"database": "lobbying", "table": "lobbying_activities", "rows": [[1590743, "a80a223d-d087-44f6-bb70-eaec1fd4d3a3", "Q3", "CROSSROADS STRATEGIES, LLC", 400531586, "LUMARA HEALTH", 2014, "third_quarter", "PHA", "Implementation issues related to the Pharmaceutical Quality, Security, and Accountability Act (P.L. 113-54); H.R.3089, Compounding Clarity Act of 2013; FDA related issues-specifically pharmacy compounding.", "HOUSE OF REPRESENTATIVES,SENATE", 60000, null, 0, 0, "2014-10-16T19:02:50.517000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1590743"], "units": {}, "query_ms": 97.44262997992337, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}